Fecha de publicación: 09/10/2024 Fuente: PubMed "hive" J Allergy Clin Immunol Glob. 2024 Sep 6;3(4):100339. doi: 10.1016/j.jacig.2024.100339. eCollection 2024 Nov.ABSTRACTWe present a case of secondary T-cell deficiency particularly affecting CD4 T cells, along with the emergence of chronic spontaneous urticaria in a patient following COVID-19 vaccination. The condition was partially managed with omalizumab after initial first-line therapy proved ineffective.PMID:39380982 | PMC:PMC11459643 | DOI:10.1016/j.jacig.2024.100339